ストックスクリーナーアプリを入手
122.07
0.55%
0.6184
前日終値:
$121.45
開ける：
$122.49
24時間の取引高:
156.98K
Relative Volume:
0.27
時価総額：
$6.09B
収益：
$338.46M
当期純損益:
$-310.96M
株価収益率:
-18.69
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
+2.82%
1か月 パフォーマンス:
+0.69%
6か月 パフォーマンス:
+9.36%
1年 パフォーマンス:
+34.92%
1日の値動き範囲:
$121.45
$124.53
1週間の範囲:
$115.31
$124.53
52週間の値動き範囲:
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
名前
Axsome Therapeutics Inc
セクター
電話
(212) 332-3241
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
121.96 | 6.06B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.23 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.00 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.72 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
768.60 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.08 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 再開されました | Wells Fargo | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-03 | 開始されました | Oppenheimer | Outperform |
| 2025-04-07 | 開始されました | Jefferies | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-31 | 繰り返されました | Mizuho | Outperform |
| 2024-09-03 | 開始されました | Wells Fargo | Overweight |
| 2024-08-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-07-22 | 開始されました | Needham | Buy |
| 2024-04-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2024-01-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-08-08 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-01-05 | 開始されました | Piper Sandler | Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2022-09-07 | 再開されました | Mizuho | Buy |
| 2021-08-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | 開始されました | Berenberg | Buy |
| 2021-01-08 | 開始されました | Jefferies | Buy |
| 2020-12-16 | 開始されました | Mizuho | Buy |
| 2020-09-29 | 開始されました | BofA Securities | Underperform |
| 2020-09-10 | 開始されました | Morgan Stanley | Overweight |
| 2020-04-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-14 | 開始されました | Cowen | Outperform |
| 2019-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-16 | 繰り返されました | Guggenheim | Buy |
| 2019-10-16 | 開始されました | Guggenheim | Buy |
| 2019-09-18 | 開始されました | William Blair | Outperform |
| 2019-05-28 | 開始されました | SunTrust | Buy |
| 2019-05-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-04-08 | 開始されました | SVB Leerink | Outperform |
| 2019-03-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-10-03 | 再開されました | Brean Capital | Buy |
| 2015-12-15 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Axsome Therapeutics Inc (AXSM) 最新ニュース
Will Axsome Therapeutics Inc. (19X) stock deliver stable dividendsJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
H.C. Wainwright maintains Axsome stock Buy rating, $190 target - MSN
Can Auvelity Drive Axsome's Growth Through the Rest of 2025? - The Globe and Mail
Obstructive Sleep Apnea Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Apnimed, Eli Lilly and Company, Axsome Therapeutics/Jazz Pharmaceuticals, Bioprojet Pharma - Barchart.com
Obstructive Sleep Apnea Market Insights Highlight Expanding - openPR.com
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - Mitrade
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - The Motley Fool
Axsome Sues Apotex to Block Copies of Symbravo Migraine Drug - Bloomberg Law News
Will Axsome Therapeutics Inc. (19X) stock outperform global peers2025 Top Gainers & Real-Time Market Trend Scan - newser.com
How Axsome Therapeutics Inc. (19X) stock trades after rate cuts2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Can Axsome Therapeutics Inc. stock withstand economic slowdownOptions Play & Community Driven Trade Alerts - newser.com
Axsome Therapeutics ($AXSM) Is Paying a $7.75M Settlement to Investors — Here’s How to Get Your Shar - TradingView
Piper Sandler Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $148 - 富途牛牛
Axsome Settles Investors' Drug Approval Suit For $7.8M - Law360
Axsome Therapeutics ($AXSM) $7.75M Investor Settlement - TradingView
Axsome Therapeutics and $AXSM Investors Finalise $7.75M Settlement Agreement - TradingView
Cantor Fitzgerald Has Weak Forecast for AXSM FY2026 Earnings - MarketBeat
Assenagon Asset Management S.A. Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics COO Jacobson sells $1.15 million in shares By Investing.com - Investing.com Canada
Axsome therapeutics COO Jacobson sells $1.15 million in shares - Investing.com
Axsome Therapeutics (NASDAQ:AXSM) COO Mark L. Jacobson Sells 10,000 Shares - MarketBeat
Axsome to Settle Class Suit Over Migraine Drug for $7.75 Million - Bloomberg Law News
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Buy" by Analysts - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) COO Sells $5,241,237.84 in Stock - MarketBeat
Pallas Capital Advisors LLC Purchases 2,492 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
10,400 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Strs Ohio - MarketBeat
Herriot Tabuteau Sells 15,254 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Herriot Tabuteau Sells 27,907 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Herriot Tabuteau Sells 19,719 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Market Moves: Can Axsome Therapeutics Inc. continue delivering strong returnsTrade Risk Assessment & Stepwise Swing Trade Plans - khodrobank.com
Intech Investment Management LLC Boosts Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
How Investors May Respond To Axsome Therapeutics (AXSM) Showcasing Late-Stage CNS Pipeline Data at Psych Congress - Yahoo Finance
Voya Investment Management LLC Sells 3,742 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - خودرو بانک
Tech Rally: How does Axsome Therapeutics Inc compare to its peers2025 Stock Rankings & Fast Momentum Entry Tips - خودرو بانک
FY2026 EPS Estimates for AXSM Decreased by Cantor Fitzgerald - Defense World
Rhumbline Advisers Has $6.39 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics COO sells shares for $5.2 million By Investing.com - Investing.com Australia
AQR Capital Management LLC Purchases 20,152 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics COO sells shares for $5.2 million - Investing.com
Narcolepsy Market: Insights into Epidemiology, Treatment - openPR.com
User - FinancialContent
Whale Trades: Is Axsome Therapeutics Inc stock trending bullishMarket Movers & Verified Chart Pattern Signals - خودرو بانک
Axsome Therapeutics Inc (AXSM) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
大文字化:
|
ボリューム (24 時間):